India's Insurtech Unicorn Heads to Dalal Street

India's IPO pipeline for 2026 is stacked with familiar consumer-tech names, but one of the more interesting candidates flies a little under the radar: Acko, the digital-first general insurer that has spent the better part of a decade trying to make buying insurance feel less like filling out a tax form. With bankers appointed and a draft prospectus being prepared, the Acko IPO is now firmly on the watchlist for 2026–27. Here's where things actually stand, stripped of the hype.

Acko IPO at a glance

Before going further, one important clarification: the Acko IPO is in the preparation stage, not the open-subscription stage. There is no price band or subscription date yet. What we do have are sourced reports on the structure and timeline, and they paint a fairly clear picture.

[](https://www.72ipo.ai/) That valuation target is worth pausing on. At $2–2.5 billion, Acko would be pricing itself meaningfully above its last private round the 2021 Series D that minted its unicorn status at roughly $1.1–1.4 billion. In a market where several recent listings have struggled to justify their private valuations, that step-up is the first thing institutional investors will scrutinize.

What does Acko actually do?

Founded in 2016 by Varun Dua and Ruchi Deepak, Acko is a digital-first general insurer meaning it sells policies directly through its own app and website rather than through the traditional army of agents. Its core lines are auto, health, and travel insurance, alongside an embedded insurance business that plugs coverage into the checkout flows of e-commerce and travel-tech partners.

The model matters more than the product list. A conventional insurer carries the fixed cost of a large agent network and inherits messier customer data filtered through intermediaries. Acko's direct, cloud-based approach gives it richer first-party data on its customers, which in principle sharpens its risk pricing and lowers acquisition costs. That data advantage is the heart of the bull case.

The financials: losses narrowing, revenue climbing

Insurtech valuations live and die on the path to profitability, so this is where retail investors should focus.

The encouraging signal: Acko has been growing the top line while shrinking the bottom-line bleed. Reports indicate revenue grew around 35% in FY25 to roughly ₹2,837 crore, while net losses narrowed significantly year on year. Various sources peg the FY25 net loss between roughly ₹420 crore and ₹424 crore, down sharply (over 50%) from the prior year.

The caution flag: it is still a loss-making company heading into a public listing. Ahead of the IPO, Acko reportedly trimmed about 5% of its workforce (around 60 employees), citing AI-led automation a move that reads as margin discipline but also as a reminder that the road to sustained profit isn't finished. Investors will want to see whether the loss-narrowing trend holds through the DRHP financials, not just stop at one good year.

Why the confidential DRHP route?

Acko is filing through SEBI's confidential pre-filing route, the same path several large new-age companies have favoured. The appeal is straightforward: it lets a company complete the back-and-forth regulatory review with SEBI without exposing sensitive financials to competitors and the public until much later in the process. It also buys timing flexibility Acko can wait for a friendlier listing window rather than being locked into a calendar.

This is also why precise dates remain fuzzy. Under the confidential route, the detailed public disclosures arrive only when the company converts to an updated draft (UDRHP) closer to launch. Until then, treat every number as a sourced estimate, not a confirmed figure.

The bigger picture: insurance penetration and the digital shift

Acko sits at the intersection of two genuinely large structural trends in Indian financial services. First, insurance penetration in India remains well below global averages, leaving a long runway for growth. Second, distribution is steadily shifting from offline, agent-led sales toward digital channels that are cheaper to run and generate better data.

If you believe both trends continue, a profitable, data-rich, digital-native insurer is an attractive way to play them. The open question and it's the one the IPO will test is whether Acko can convert that thesis into durable profit before public-market investors lose patience with losses.

What retail investors should watch

When the DRHP eventually lands, here's a practical checklist before forming any view:

• The fresh-issue vs OFS split: a large OFS skewed toward early investors cashing out reads differently than fresh capital funding growth.
• The valuation justification: does the $2–2.5 billion target hold up against listed peers and Acko's own loss profile?
• Combined ratio and underwriting quality: for any insurer, this is the real signal of whether the core business makes money.
• The loss trajector: is FY26 continuing the FY25 improvement, or was that a one-off?
• Use of proceeds: growth, solvency capital, or simply liquidity for existing shareholders?

The Acko IPO is one of the more thoughtful entries in India's 2026–27 insurtech pipeline: a real business, in a genuinely under-penetrated market, with improving financials and a clear data edge. The catch is the familiar new-age one it's still unprofitable and pricing itself well above its last private mark. None of that is disqualifying, but it's exactly why the DRHP details will matter far more than the headlines.

We'll be tracking the Acko DRHP, GMP signals, subscription data, and listing-day performance the moment they go live. Follow the full Acko IPO timeline and every Mainboard and SME issue on **www.72ipo.ai**.